Source: Myeloma : nature.com subject feeds
Post Content
IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma
by | Aug 30, 2024 | Myeloma News | 0 comments
Recent Content
- Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
- Study Finds Endometriosis May Be Linked to Traumatic Experiences
- FDA Approves Teal Wand, First At-Home Self-Collection Cervical Cancer Screening Device
- Eraglusib Combo Improves Survival in Metastatic Pancreatic Cancer
- A Thank You to Nurses and the Support That Lasts Beyond Cancer Care
- Study: RSV Vaccine Response in Lung Transplant Recipients
- Live Zoster Vaccine May Reduce Risk of Cardiovascular Events by 23%, Study Finds
- Imfinzi Regimen Improves Disease-Free Survival in Early Bladder Cancer
- Student Advocacy in Pharmacy
- Plozasiran Shows Promise as Cholesterol-Lowering Treatment for Mixed Hyperlipidemia